:: Avemar Immunology Program ::

Review Survey of autoimmune diseases	»
Types of cancer
Rheumatoid arthritis	»
SLE	»

Publication update
J. Pediatr Hematol Oncol (10: 631-635. October 2004.) "Fermented wheat germ extract reduces chemo-therapy induced febrile neutropenia in pediatric cancer patients" Download (.pdf)
British Journal of Cancer (89: 465-469, 2003.) "A medical nutriment has supportive value in the treatment of colorectal cancer" Download (.pdf)
Journal of Biololgical Chemistry (277: 46408-46414, 2002.) "Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells." Download (.pdf) (-->)

Review
Experiments up to this date have tested the effect of Avemar on two autoimmune diseases, namely rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), complemented by a preliminary clinical study of patients suffering from RA. » More

Who is Who?
List of researchers and contributors participating in the Avemar Research Project. » All researchers

Product information
Indications and the registrational status of Avemar, a medical nutriment for cancer patients. » More

Preclinical results
The first indications of Avemar's effectiveness: ground-breaking results in animal experimental models. » More

References
View the most important scientific publications relating to Avemar and download them in PDF format. » More

Mode of action
More about what lies behind Avemar's effect mechanism. » More

Clinical oncological effects
Increasing the likelihood of survival, inhibiting progression, improving the quality of life, decreasing instances of febrile neutropenia, introducing Avemar's clinical effectiveness with a focus on selected cancer types. » More

Frequently asked questions
» More